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Rabies claims approximately 59,000 human lives annually and is a potential risk to 3.3 
billion people in over 100 countries worldwide. Despite being fatal in almost 100% of 
cases, human rabies can be prevented by vaccinating dogs, the most common vector, 
and the timely administration of post-exposure prophylaxis (PEP) to exposed victims. For 
the control and prevention of human rabies in N’Djamena, the capital city of Chad, a free 
mass vaccination campaign for dogs was organized in 2012 and 2013. The campaigns 
were monitored by parallel studies on the incidence of canine rabies based on diag-
nostic testing of suspect animals and the incidence of human bite exposure recorded 
at selected health facilities. Based on the cost description of the campaign and the 
need for PEP registered in health centers, three cost scenarios were compared: cumu-
lative cost-efficiency of (1) PEP alone, (2) dog mass vaccination and PEP, (3) dog mass 
vaccination, PEP, and maximal communication between human health and veterinary 
workers (One Health communication). Assuming ideal One Health communication, the 
cumulative prospective cost of dog vaccination and PEP break even with the cumulative 
prospective cost of PEP alone in the 10th year from the start of the calculation (2012). 
The cost efficiency expressed in cost per human exposure averted is much higher with 
canine vaccination and One Health communication than with PEP alone. As shown 
in other studies, our cost-effectiveness analysis highlights that canine vaccination is 
financially the best option for animal rabies control and rabies prevention in humans. 
This study also provides evidence of the beneficial effect of One Health communication. 
Only with close communication between the human and animal health sectors will the 
decrease in animal rabies incidence be translated into a decline for PEP. An efficiently 
applied One Health concept would largely reduce the cost of PEP in resource poor 
countries and should be implemented for zoonosis control in general.
Keywords: cost efficiency, One health, chad, rabies control and prevention, post-exposure prophylaxis
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inTrODUcTiOn
Rabies is a viral zoonotic disease first described in Mesopotamia 
in 3000 B.C. Humans are infected mainly through the domestic 
dog (1). Once clinical signs of rabies become apparent, the out-
come is nearly 100% fatal (2). Annual human deaths due to rabies 
are estimated at 59,000 cases worldwide, and over 29 million 
people are exposed and need post-exposure prophylaxis (PEP) 
(3). Approximately 99% of these cases occur in Africa and Asia (1, 
3). Animal rabies can be controlled through immunization and 
population management of the reservoir species (4). Vaccination 
of domestic dogs, their confinement, and application of quaran-
tine measures following importation are key prevention strategies 
(5). With effective control measures in place, human exposure to 
rabies can be drastically reduced leading to elimination of dog-
mediated rabies (6).
In the United States, dog-mediated rabies was eliminated 
through vaccination of dogs (7), as vividly described by Tierkel 
et al. (8). This success story has been replicated in Latin America, 
where rabies transmitted by domestic dogs has been significantly 
reduced (9), and the same approach shows positive effect in 
Tanzania and Bali (10, 11). Despite ample proof of value for public 
health, control of rabies in the animal reservoir remains very 
limited in many endemic countries to date and, in the absence of 
dog vaccination, human rabies cases are only prevented through 
administration of PEP (1, 12).
The biggest challenges in Africa and Asia are free roaming 
dog populations, limited available resources for dog owners, 
limited veterinary and human health infrastructure, low disease 
awareness, and absence of efficient communication between the 
veterinary and the human health sectors (13, 14).
The absence of efficient control at the source is excessively 
costly in terms of disability-adjusted life years (DALY) lost due 
to premature death and the cost of PEP to the public and private 
sectors (14, 15). Economic losses also occur in the agricultural 
sector due to loss of livestock.
The cost of animal rabies vaccination depends on the respec-
tive context and varies from country to country (16). Cost for 
PEP also fluctuates greatly between countries and vaccination 
scheme applied (17, 18). The highest cost accrues from rabies 
immunoglobulin (RIG) which, according to WHO guidelines, 
must be injected on day 0 together with a first active vaccination 
dose for category 3 exposures (single or multiple transdermal 
bites or scratches) (1). However, in most endemic countries, RIG 
is not available or not affordable for victims, and PEP is limited 
to wound treatment and administration of anti-rabies vaccine.
In N’Djamena, Chad, rabies research studies began in 2000 
and continue to date. In 2001, a pilot dog vaccination campaign 
showed that the societal cost for vaccination was 1,610 FCFA (2.6 
USD, current exchange rate) per vaccinated animal (19).
In 2008, the incidence of human rabies was estimated at 0.7 
persons per 100,000 inhabitants, using a decision tree model 
(20). The same study showed that over 99% of reported animal 
bites were inflicted by owned, but free roaming, dogs. Based on 
these data, a model was established, forecasting transmission of 
rabies within the dog population and between dogs and humans. 
This model proposed that the cumulative cost of a dog mass 
vaccination campaign combined with PEP would be less than the 
cumulative costs of PEP, reaching a break-even point 6 years after 
the start of the intervention (21). The cost effectiveness of dog 
vaccination combined with PEP was proposed to be higher than 
for an exclusive PEP approach from the fifth year onward.
The present study aims to validate and update the model 
predictions, through the detailed cost analysis of a citywide 
mass vaccination campaign carried out in 2012 and 2013 in 
N’Djamena. Together with data from the continuous reporting 
of animal rabies cases diagnosed at the rabies laboratory of the 
Institut de Recherche en Elevage pour le Developpement (IRED) 
and human bite exposures reported from selected health cent-
ers, a prospective cost effectiveness analysis between PEP alone 
(scenario 1) and dog vaccination with PEP (scenario 2) was done.
Following an animal bite, communication between human 
and animal health facilities potentially contribute to a high cost 
reduction for PEP, financial gains from prevented exposures, 
and overall number of DALY averted. To estimate the potential 
extent of the added value through maximal communication 
between veterinarians and human health workers, a third 
 scenario was included envisioning ideal One Health communi-
cation (scenario 3).
The costs described in this article provide the basis for the 
planning and organization of a national mass vaccination cam-
paign (22) and a proposed approach to lower expenses due to 
rabies in view of elimination of dog-mediated human rabies by 
2030, as jointly outlined by WHO, FAO, OIE, the Global Alliance 
for Rabies Control, and the international community (23).
MaTerials anD MeThODs
study site
The study took place in N’Djamena, the capital city of Chad, 
with a rapidly increasing population (3.3% growth rate) of 
approximately 1 million inhabitants in 2012 in an area of 520 km2. 
The town is divided into 10 districts and 56 quarters (24). The 
vaccination intervention and data collection on animal rabies 
incidence and incidence of human bite exposure covered the 
entire administrative area of the city.
Planning and cost Description of the 
Mass Vaccination campaign
The vaccination intervention was organized by a tripartite part-
nership comprised of the Swiss Tropical and Public Health (Swiss 
TPH) Institute, the Centre de Support en Santé Internationale 
(CSSI), and the Institut de Recherches en Elevage pour le 
Développement (IRED). Selected members of these three institu-
tions formed the supervisory and technical committees. District 
and quarter chiefs were invited to an information workshop prior 
to the campaign and were actively involved in notifying the public 
and planning the progression. The campaign was launched in both 
years by the minister of livestock at the World Rabies Day cel-
ebrations on 28th September. Vaccinators were recruited among 
local animal health workers and veterinarians and were trained 
on animal handling, vaccination, and registration techniques. 
The campaign was advertised prior to the start through posters 
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distributed by the responsible administrative officers. During the 
campaign, radio and loud speaker announcements informed the 
public on the progression and location of the vaccination posts. 
Loudspeakers were also used to inform the populations close 
to the respective posts on the vaccination days. Both years, the 
vaccination campaign lasted 13 weeks, progressing from district 
to district. Vaccination days were held Friday to Sunday. Each 
Monday and Tuesday after vaccination in a given zone, data on 
the coverage level were collected through a household study and 
counting of dogs in the street on random transects. The data 
sets where combined in a Bayesian model that estimated total 
dog population, percent of ownerless dogs, and overall coverage 
level. A real-time preliminary analysis done in the field guided 
the campaign progression. A detailed coverage analysis was done 
after the campaign period each year. The detailed methodology 
of this analysis is published elsewhere (25).
Wednesday and Thursdays were used for planning and meet-
ing with authorities in the upcoming vaccination zone. Locations 
of vaccination posts were defined in agreement with the com-
munity authorities and were usually close to the house of a block 
chief, who provided tables and chairs. GPS data on the location 
of each vaccination post were collected.
The campaign was funded in equal parts by the UBS Optimus 
Foundation (material, vaccine, and research cost) and the minis-
try of livestock in Chad (logistics and salary). Based on the dog to 
human ratio estimated during a dog demographic survey in 2001 
and extrapolated to 2012, the required vaccination doses were 
estimated at 50,000. The Rabisin® vaccine doses were provided 
by Merial at a cost of 143 FCFA (0.28 USD, exchange rate 2012) 
per dose. In addition, Merial provided collars to mark vaccinated 
animals for 150 FCFA (0.29 USD, exchange rate 2012) each and 
vaccination certificates free of cost. The cold chain was ensured 
using storage boxes with cooling elements that were delivered 
together with the vaccine doses. Syringes and needles were 
procured locally.
The 30 vaccinators were split into 10 teams of 3 people: one 
responsible for vaccination and collaring and two for register-
ing the animal and completing the vaccination certificate. Three 
trucks with drivers transported the 10 teams. Each vehicle was 
attributed to a supervisor responsible for three to four teams. The 
teams were each equipped with a cooler box for the vaccine and a 
box containing all necessary material (syringes, needles, registra-
tion forms, muzzle, gloves, first aid kit). Every day the material 
was checked by the supervisor against a control sheet and the 
performance of the post (number of vaccinated animal by species, 
working time, vials used) was reported for each team on a data 
sheet. Supervisors were responsible to replenish posts under their 
supervision and provide lunch and water. Each supervisor had 
additional cooler boxes for vaccine and water bottles. Supervisors 
decided in consultation with the block chiefs and members of 
the coordination team on the relocation of posts when owner 
attendance was low. A detailed list of the costs is listed in Table 1 
for both years. Material cost is depicted by unit whereas cost for 
personnel and transport is calculated per day. Each campaign 
lasted for 37 working days, from October to December 2012 and 
2013, respectively. Because the campaign period included two 
public holidays, vaccinators were paid for 39 days in total in both 
years. Car rental and fuel cost are calculated for a total of 50 days, 
including 37 working days and 13 days of sensitization. In 2013, 
the information campaign was considerably strengthened, which 
is reflected in the difference between the respective budget lines 
in 2012 and 2013.
The overall public cost of the vaccination campaign includes 
material cost, the cost for personnel and transport, as well as cost 
for the sensitization campaign. In addition to these public costs, 
the cost of the private sector is considered. These include dog 
owner expenditures for transportation to the vaccination post 
and loss of work time. The average waiting time at a post was 
assumed to be 1 h, valued at 327 FCFA (0.6 USD, exchange rate 
2012) based on monthly per capita income in Chad of 52,325 
FCFA (104 USD, exchange rate 2012) (26). For transport, the 
mean cost of 650 FCFA (1.3 USD, exchange rate 2012) was 
assumed, which corresponds to the price of one liter of fuel. The 
sum of public and private cost forms the societal costs.
epidemiological Monitoring
To assess effectiveness of the intervention, the vaccination 
campaign was accompanied by an epidemiological study on the 
incidence of human exposure to animal bites and a study on the 
incidence of dog rabies cases in N’Djamena.
Data on bite exposure was collected in collaboration with 
selected health facilities, including public health centers, hos-
pitals, pharmacies, private medical clinics, and a few veterinary 
practices. Overall 91 facilities were contacted, with 61 completing 
at least one questionnaire during the study period, from June 2012 
to December 2014. The facilities were visited by study members at 
least once a week to collect completed questionnaires. Collected 
data included basic information about the bite victim (sex, age, 
address), the status of the animal (species, vaccination history, 
alive/deceased), bite history, severity of the wound(s) inflicted, 
and the treatment recommendation. Data were double entered 
into Access® databases by the data management team at CSSI. The 
analysis was done with Stata/IC™ 14. During the data analysis, it 
was observed that recommendation for PEP made by health per-
sonnel was based on the severity of the bite wound rather than on 
the status of the biting animal. This meant that reported numbers 
of PEP could not be used as a proxy for human rabies exposure 
for the DALY calculation nor to estimate the actual number of 
PEP needed. Therefore, a dummy variable was assigned to each 
reported case defining victim rabies exposure risk according to 
fate and vaccination status of the biting animal: (1) high risk 
exposure (PEP definitely needed for the bite victim) was defined 
when the animal had been killed, had died, or was missing fol-
lowing the attack, regardless of reported vaccination status; (2) 
moderate exposure risk (PEP need depending on the observation 
result) was attributed to bites inflicted by animals with unknown, 
outdated, or no vaccination history which were alive and could 
be placed under observation; (3) bites inflicted by a confirmed 
vaccinated animal which was alive and under observation were 
not considered as an exposure to rabies (no PEP needed).
These exposure risk categories were used for DALY calcula-
tions and to estimate actual number of PEP needed (as opposed to 
reported number of PEP). In addition to bite cases, information 
on the cost of human anti rabies vaccine and the vaccination 
TaBle 1 | list of costs and expenses of dog mass vaccination campaigns in 2012 and 2013.
2012 2013
cost item number of units Price per unit Total cost number of 
units
Price per unit Total cost
Public sector
Material cost
Animal vaccine 18,182 143 2,600,026 22,306 143 3,189,758
Human vaccine 100 21,703 2,170,340 40 21,337 853,480
Collars 18,182 150 2,727,300 22,306 150 3,345,900
Vaccination certificate Included in vaccine cost
Syringes and needles 18,182 40 727,280 22,306 40 892,240
Tables and chairs Provided by block chiefs
Material transport box 10 20,300 203,000 1 20,300 20,300
Muzzle 14 6,400 89,600 3 6,400 19,200
Rope 10 8,100 81,000 2 1,350 2,700
Registry 10 8,000 80,000 Reused
Other writing and documentation material (e.g., pen, stamp, paper) NA NA 329,750 NA NA 126,850
Work protection (face mask, coat, first aid kit) NA NA 495,348 NA NA 617,200
Consumables (e.g., garbage bags, gloves) NA NA 45,300 NA NA 8,800
Cooler boxes 17 20,441 347,500 Reused
Cost for personnel
Training of vaccinators NA NA 250,000 NA NA 314,750
Daily wages vaccinators 39 151,923 5,925,000 39 151,923 5,925,000
Daily wages supervisors 39 10,000 390,000 3 390,000 1,170,000
Daily wages driver (vaccination and sensitization) 50 11,700 585,000 50 13,860 693,000
Fees for local responsibles (district chiefs and block chiefs) 37 51,216 1,895,000 37 47,108 1,743,000
Lunch provisions (per day) 37 42,791 1,583,250 37 50,372 1,863,750
Transport cost
Transport (car rental and maintenance) 50 9,900 495,000 50 8,308 415,383
Daily fuel cost 50 36,532 1,826,576 50 40,896 2,044,824
Sensitization
Information workshop for town authorities NA NA 1,172,000 NA NA 1,296,000
T-shirts, hats, and banners 315 6,746 2,125,000 Reused
Posters 1,000 719 719,000 1,000 1,114 1,114,000
Leaflets 5,000 204 1,020,000 5,000 163 815,000
Radio announcements 39 25,000 975,000 39 47,821 1,865,000
Loudspeaker 3 20,000 60,000 Reused
Poster distribution and cost for loudspeaker campaign (per day) 20 12,040 240,800 52 15,731 818,000
Admin and communication cost
Coordination cost NA NA 1,365,000 NA NA 1,215,000
Administrative cost NA NA 200,000 NA NA 100,000
Communication supervisor (per person) 3 190,000 570,000 3 195,000 585,000
Communication coordination (per person) 3 131,667 395,000 3 130,000 390,000
Other cost 1 353,750 353,750 1 5,000 5,000
Total public sector 32,041,820 31,449,135
Mean public cost per dog vaccinated 18,182 1,762 22,306 1,410
Private sector
Lost working time (60 min, 327 CFA) 18,182 327 5,945,514 22,306 327 7,294,062
Transport to vaccination post 18,182 650 11,818,300 22,306 650 14,498,900
Total private sector 17,763,814 21,792,962
Societal cost of the vaccination campaign 49,805,634 53,242,097
Overall cost in USDa 98,715 110,747
Cost per dog vaccinated in FCFA 2,739.28 2,387
Cost per dog vaccinated in USD 5.43 4.96
a1 USD = 504.54 FCFA (October 2012); 480.75 FCFA (October 2013).
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schedule prescribed for PEP was collected during the health 
facility based study.
The most commonly used protocol was the Essen 5 dose 
scheme. Other protocols, applied rarely, were the Essen 4 dose 
scheme and the Zagreb protocol. The details of the protocols are 
described in Table 2.
In parallel to the health facility study, the results of rabies 
diagnostic tests routinely performed at the IRED laboratory 
on suspect animals were collected. The observed percentage 
of rabies positive dogs among all dogs tested was used as a 
baseline for the probability of an exposure being inflicted by 
a rabid dog.
TaBle 2 | The three different post-exposure prophylaxis protocols used in n’Djamena [table adapted from hampson et al. (17)].
Protocol number of clinical 
visits
Days of injection after 
exposure
number of injections 
per day
Overall vaccine quantity 
needed (ml)
administration 
pathway
approved by
Essen 5 doses 5 0,3,7,14,28 1,1,1,1,1 5a IM WHO (1992)
Essen 4 doses 4 0,3,7,14 1,1,1,1 4a IM ACIPb (2009)
Zagreb 3 0,7,21 2,1,1 2a IM WHO (1992)
aCalculated on the basis of 0.5 ml per dose.
bAdvisory Committee on Immunization Practices.
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cost comparison
The evidence collected on cost of dog vaccination and PEP, 
together with the epidemiological background information, 
allowed for evaluation of different control scenarios in regard to 
their comparative cost effectiveness. The three different scenarios 
compared were (1) cost of PEP alone, (2) cost of PEP and dog 
mass vaccination intervention, without communication between 
the human health and veterinary sector, and (3) cost of PEP and 
dog mass vaccination, with maximal communication between 
human and animal health workers (One Health paradigm). 
Measures for improvement of communication were not part of 
the study, so scenario 3 is uniquely hypothetical. Under ideal One 
Health communication conditions, a veterinarian would auto-
matically be contacted for each bite case reported and cases of 
unknown vaccination status would become negligible, provided 
that the dog was owned and an effective registration system was 
in place.
The overall cost of PEP was calculated following examples 
from other resource limited countries (17, 27) and included 
medical and non-medical expenditures. Medical fees were com-
prised of cost of vaccine multiplied by the doses needed for a 
given schedule, the cost for syringes and needles (here included 
in the vaccine cost), and institutional costs (salaries, administra-
tion). Non-medical costs were costs accrued by victims, including 
transport and lost working time similar to private costs for vac-
cination of dogs.
For the calculation of PEP cost alone (scenario 1), the monthly 
number of PEP recommended by the health personnel within the 
first 6 months of the study period was used as a basis.
Yearly cost for canine vaccination was derived from the cost 
description of the vaccination campaigns in 2012 and 2013. From 
2014 onward, it was assumed that the two campaigns would lead 
to interruption of transmission, assuming no reintroduction 
from outside the vaccinated area, and therefore, only a baseline 
cost for control of reintroduction and emergency vaccination 
was included. Cost of PEP for scenario 2 was calculated based on 
the number of PEP recommended by health personnel observed 
during the study period. From 2015 onward, the mean number of 
registered PEP in 2013 and 2014 was used as the calculation basis.
Cost for the hypothetical scenario 3 was calculated by sum-
ming the dog vaccination cost as used in scenario 2 and the yearly 
actual number of PEP needed based on the exposure risk vari-
able defined described above. It was assumed that maximal One 
Health communication would lead to better decision-making in 
regard to need of PEP and that there would be fewer animals with 
unknown vaccination status. Based on the coverage rate achieved 
during the vaccination campaign (25), 70% of the registered bites 
from dogs with unknown or unconfirmed vaccination were con-
sidered as vaccinated and further excluded from the number of 
exposures in the scenario. In addition it was assumed that in case 
of a bite inflicted by an unvaccinated dog, victims would initially 
start treatment, but discontinue if the animal was still alive after 
the 10-day observation period.
The age distribution of victims exposed to rabies used for the 
calculation of averted DALY was based on a previous study on 
animal rabies cases in N’Djamena (28) reporting proportion of 
age groups among victims of rabies positive dogs as follows: age 
0–5 years 19%; age 5–15 years 36%, and age above 15 years 45%.
For the estimation of averted life years lost by a given scenario, 
it was assumed that in the absence of PEP, rabies exposure would 
lead to death in 19% of cases (29). It was further assumed that 
66% of suspect exposures are inflicted by a rabid animal. This 
assumption is based on the proportion of animals tested positive 
among all animals sent for rabies diagnosis to IRED during the 
study period.
Because clinical rabies inevitably leads to death within 
days, only averted life years lost were considered without 
any adjustment for disability (30). We used the standard 
formula described by Murray within the model life-table West 
Level 26 (31).
The discount rate used was 4%. The parameter for the age 
weight function (b) utilized was 0.04 and the constant (C) was set 
at 0.1658. The disability weight function was defined as 1.
Cost efficiency of PEP alone was calculated as discounted 
cumulative cost of baseline PEP number before the start of 
the mass vaccination campaigns divided by the cumulative 
number of DALY averted. Cost efficiency of the mass vac-
cination campaign and PEP together was calculated from the 
cumulative discounted cost of canine vaccination and number 
of PEP registered during the intervention period divided by the 
difference between the cumulative number of DALY averted 
by PEP alone and the cumulative number of DALY averted by 
vaccination of dogs.
ethical consideration
This study was authorized by the ministry for higher education 
and scientific research (Ministère de l’Enseignement Supérieur et 
de la Recherche Scientifique) under the document number N°012/
PR/PM/MES/SG/DGESRSFP/DRST/012 on May 31, 2012.
The Mayoral office of N’Djamena was informed about the 
study and gave consent. All personnel involved in immunization 
of dogs were vaccinated against rabies before participating.
FigUre 2 | Mean number of dog bites inflicted per time period and 
proportion of vaccination status categories. July to September 2012 
corresponds to the pre-vaccination campaign period. June 2012 was 
excluded due to very low overall number of cases reported.
FigUre 1 | Distribution of total number of bite cases reported for the 
10 different districts of n’Djamena over the whole study period.
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resUlTs
During the vaccination campaign, a total of 18,182 dogs were 
vaccinated in 2012 and 22,306 in 2013. The analysis revealed 
an overall coverage of 71% in both years. On the district level, 
observed coverage varied widely ranging from 33 to 86% 
depending on the cultural and socioeconomic background 
of the area. The dog population of N’Djamena was estimated 
to be around 30,000 of which only 14% are ownerless (data 
from 2013). The intervention led to a considerable drop in 
dog rabies incidence from 0.7/1,000 in 2012 to 0.07/1,000 in 
2014. Detailed coverage analysis and epidemiological data are 
presented elsewhere (25).
The total cost for the 2012 campaign was 98,715 USD 
(49,805,634 FCFA), and in 2013 the cost was 110,747 USD 
(53,242,097 FCFA). Expressed in cost per dog vaccinated, 5.43 
USD were spent in 2012 and 4.96 USD in 2013 (cats and pri-
mates were excluded). The difference between the 2  years was 
due to higher expenses for sensitization to boost the vaccination 
coverage. The success of this intensified information campaign is 
reflected in the higher number of dogs vaccinated in 2013, which 
increased the overall cost but lowered the cost per animal vac-
cinated. In both years, the public cost represented roughly 2/3 of 
the societal cost (64% in 2012 and 59% in 2013).
Over the 2½-year study period, 1,203 questionnaires on bite 
victims were collected, of which 1,143 matched the inclusion 
criteria (victim was from N’Djamena, bite inflicted by a mammal 
species). All recorded incidences were category III exposure, with 
902 (79%) inflicted by a dog, 56 (5%) by a cat, and 15 (1%) by a 
primate, while in 170 (15%) the species was not specified.
Figure  1 shows the distribution of bite cases by district in 
N’Djamena. The distribution reflects the difference in dog to 
human ratio observed during the vaccination campaign (25).
The highest proportion of bite exposure (42%) was reported 
in the age group of children younger than 13  years. Overall, 
46% of biting animals had a confirmed vaccination status. The 
vaccination campaign only slightly (10%) increased the number 
of confirmed vaccinated animals over the period of the mass vac-
cination intervention (Figure 2).
In 99% of PEP recommendations, the scheme applied was 
the Essen 5 dose regimen, while the remaining PEP treatments 
followed the Essen 4 dose or Zhagreb regimen. As the study did 
not include a follow up of the victims, information on complete-
ness and success of the treatment was not collected. Details on 
the three different treatment schemes are presented in Table 2. 
Because the number of Essen 4 dose and Zagreb regimens recom-
mended was negligible, only the cost of the Essen 5 dose regimen 
was considered for the cost calculation. It was assumed that all 
victims underwent wound cleaning as recommended by WHO 
(washing with soap and water for 15 min) (1) and that 40% of 
victims were accompanied by a parent. One completed course 
of PEP, therefore, incurred a cost to society of 198 USD (97,512 
FCFA) (Table 3).
In total, 455 (38%) victims were recommended to follow PEP 
treatment over the study period. In 202 of these cases, no rabies 
risk was identified according to the animal status. Conversely, 
PEP was not recommended in 36 cases where the animal status 
was defined as high risk and in 289 cases defined as moderate 
risk during the analysis phase. This indicated that in many cases 
the recommendation of health personnel was not appropriate. 
Contact with a veterinary structure was reported in only one-
third of overall bite cases (n = 349, 30%), and this number might 
be even lower due to misrepresentation. Using the example of 
reporting to IRED, it was mentioned in 144 cases (15%) that the 
animal was brought to the rabies laboratory. However, this num-
ber did not reflect the actual registered diagnostic requests at the 
rabies diagnostic facility over the same period of time. Reflecting 
this lack of communication between the veterinary and the 
human health sector, the drop in animal rabies cases induced by 
the mass vaccination campaign did not lead to a parallel reduc-
tion of PEP use.
The amount of PEP used compared to the number of 
cases within the different risk exposure groups is shown in 
Figure  3. Stratified by intervention year, a total of 284 PEP 
TaBle 3 | cost calculation for post-exposure prophylaxis treatment.
cost item for a complete five doses 
essen protocol
cost in 
FcFa
cost in 
UsDa
Unit basis
Vaccine cost (5 doses) 55,000 111.79 Per person
Cost for technician 3,307 6.72 Per person
Cost for syringes and needle 987 2.01 Per treatment
Tetanus vaccine (1 dose) 4,000 8.13 Per person
Antibiotics and anti-inflammatories 11,385 23.14 Per treatment
Water 36 0.07 Per person
Antiseptic 197 0.40 Per person
Lost work timeb 10,000 20.33 Per treatment
Transport costc 12,600 25.61 Per treatment
Total 97,512 198.20 Per treatment
Rabies immunoglobulin is not included because of unavailability in Chad.
aExchange rate 1 USD = 492 FCFA.
b40% of exposed victims are accompanied.
cExpenses for accommodation not included.
FigUre 3 | number of post-exposure prophylaxis (PeP) recommended per month compared to the number of monthly cases per exposure risk 
group.
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recommendations were estimated in 2012, while 164 were 
observed in 2013 and 149 were registered in 2014. It was 
assumed that without dog mass vaccination, the demand would 
have remained at the same level as in 2012, and therefore, PEP 
numbers from 2012 were used as a baseline for the extrapolation 
of PEP cases hypothetically occurring from 2013 onward in sce-
nario 1 (Table 4). For scenario 2, the actual reported numbers of 
PEP recommendations were applied to the respective year of the 
study period. As no data were available from 2015 onward, the 
mean number of PEP observed after the vaccination campaign 
(2013 and 2014) was applied to the following years (2015–2030) 
(Table 4). For the extrapolations, uncertainty was not accounted 
for in our recorded data for the sake of clarity.
Because PEP recommendations and exposure risk did not 
correspond, the real number of PEP needed to prevent 100% of 
human deaths from rabies would be much higher than actual 
reported PEP use. In 2012, 374 bite cases of high and moder-
ate exposure risk occurred. In 176 of these cases, PEP was not 
recommended and assumed to not be administered. Based on 
the exposure risk cases observed from the health facility data, the 
cost of effective rabies prevention in humans by use of PEP alone 
would require an investment of 36,469,488 FCFA each year as 
opposed to the observed yearly investment of 27,693,408 FCFA.
As a result of the vaccination campaign, the observed exposure 
(assuming 70% vaccination coverage) declined in 2013 to 102 
cases and in 2014 a total of 135 exposure cases were observed. 
This corresponds to a yearly mean of 119 exposures for which a 
rabies infection in the biting animal could not be excluded and 
which would, therefore, require PEP, despite the mass dog vacci-
nation, to ensure that 100% of human rabies cases are prevented. 
Compared to the mean of 156 PEP recommendations which still 
occurred after the vaccination campaign, the number of PEP 
would at least be reduced by 24% (n = 37) with better One Health 
communication.
The background for the cost analysis and the results of the 
cost comparison of the three different scenarios are presented in 
Table 4 and Figure 4.
Intervention in the animal reservoir shows a clear advantage 
over prevention measures solely on the human medical side. The 
break-even point of dog vaccination and PEP with sole use of 
PEP is forecast about 15 years after the start of intervention. If 
maximum One Health communication was achieved in addition 
to dog vaccination, the cost even point is reached only 10 years 
after the start of the intervention. This is due to reduction in 
inappropriate use of PEP (dog confirmed vaccinated and in good 
health during the observation period), which leads to lower 
human vaccine cost for scenario 3 compared to scenario 2.
The advantage of investment into the veterinary sector for the 
control of rabies in humans became even more striking when cost 
TaBle 4 | Description of the principle background for the calculation of crude cost and cost-efficiency by scenario.
cost calculation
scenario cost composition calculation basis 2012 calculation basis 
2013
calculation basis 2014 calculation 2015 onward
1 Post-exposure prophylaxis 
(PEP)
Number of recommended PEP 
registered June to December 12, 
extrapolated to 12 months
Number of 
recommended PEP 
registered June to 
December 2012, 
extrapolated to 
12 months
Number of 
recommended PEP 
registered June to 
December 2012, 
extrapolated to 
12 months
Number of recommended 
PEP registered June to 
December 2012, extrapolated 
to 12 months
2 PEP and vaccination number of recommended PEP 
registered in 2012
number of 
recommended PEP 
registered in 2013
number of recommended 
PEP in 2014
mean number of 
recommended PEP registered 
in 2013 and 2014
Cost of vaccination campaign in 
2012
Cost of vaccination 
campaign in 2013
Estimated yearly flat 
rate for reintroduction 
control and small scale 
emergency vaccination
Estimated yearly flat rate for 
reintroduction control and small 
scale emergency vaccination
3 PEP and vaccination Sum of high risk exposures and 
30% of moderate risk exposures 
registered June to December 
2012, extrapolated to 12 months
Full cost for Essen 5 
doses PEP for sum of 
high risk exposures and 
cost of three doses for 
30% of moderate risk 
exposures registered 
in 2013
Full cost for Essen 5 
doses PEP for sum of 
high risk exposures and 
cost of three doses for 
30% of moderate risk 
exposures registered in 
2014
Full cost of PEP for mean 
number of high risk exposures 
and cost for three doses 
for 30% of moderate risk 
exposures registered in 2013 
and 2014
Cost of vaccination campaign in 
2012
Cost of vaccination 
campaign in 2013
Estimated yearly flat 
rate for reintroduction 
control and small scale 
emergency vaccination
Estimated yearly flat rate for 
reintroduction control and small 
scale emergency vaccination
cost-effectiveness calculation
scenario calculation of exposures 
averted
calculation of disability-
adjusted life years (DalY) 
averted
cumulative cost after 
20 years
DalY averted after 
20 years
cost per DalY averted over 
20 years
1 Number of recommended 
PEP with high and moderate 
exposure risk background 
registered in 2012 and 
extrapolated to the following 
years
19% of number of exposures 
averted multiplied with years of life 
lost (YLL) according to different 
age classes
388,515,250 FCFA/ 
770,038 USD
6,372 60,971 FCFA/121 USD
2 Difference of extrapolated 
number of high and moderate 
risk exposure cases registered 
in 2012 and effective 
exposures (100% of high risk 
and 70% of moderate risk) 
registered in 2013 and 2014
19% of number of exposures 
averted multiplied with YLL 
according to different age classes
349,001,170 FCFA/ 
691,721 USD
9,055 38,544 FCFA/76 USD
3 Difference of extrapolated 
number of high and moderate 
risk exposure cases registered 
in 2012 and effective 
exposures (only high risk) 
registered in 2013 and 2014
19% of number of exposures 
averted multiplied with YLL 
according to different age classes
287,226,252 FCFA/ 
569,283 USD
9,055 31,721 FCFA/63 USD
For all costs, a discount rate of 4% was applied.
Exchange rate 2012 applied, 1 USD = 504.54 FCFA.
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efficiency per DALY averted was compared. The yearly number of 
DALY averted with scenario 1 was 454, whereas dog vaccination 
led to a total of 659 DALY averted each year. This showed that 
PEP use as currently applied in N’Djamena is costly but does not 
prevent human rabies cases because the exposure of humans to 
rabid animals remains, and many bite victims who are in need 
do not get PEP due to failure to consider the status of the biting 
animal.
Vaccination of the animal vector was about 30% less costly 
over a period of 20  years and this cost efficiency would be 
FigUre 4 | Display of the cost trend of the three different rabies control scenarios.
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improved by strengthening communication between animal and 
human health workers. Overall, yearly number of DALY averted 
with scenario 2 and 3 are the same, but One Health communica-
tion led to a significant reduction of PEP cost compared to dog 
vaccination alone. In the absence of such communication, the 
cumulative number of PEP prevented by the vaccination inter-
vention after 20 years was only 2,423 as compared to 4,057 doses 
of PEP prevented with scenario 3. This difference led to a slightly 
higher cost effectiveness of scenario 3 compared to scenario 2 
(Table 4; Figure 4).
Because the observed PEP recommendations in this study 
were not able to prevent human rabies deaths, we calculated the 
cost for optimal use of PEP in N’Djamena, defined as numbers 
of PEP correspond to the number of observed high and moder-
ate exposure risk cases. Compared to these estimated costs for 
prevention of 100% of human rabies deaths by PEP only, scenario 
3 would be advantageous after 6 years and scenario 2 after 8 years.
DiscUssiOn
The cost analysis of the vaccination campaigns in 2012 and 2013 
are based on a previous description of the cost of a pilot vaccina-
tion campaign in the same town (19). Compared to the former 
campaign in 2003, the costs per dog vaccinated almost doubled 
due to higher personnel cost, which reflects the economic devel-
opment over the past 10 years in Chad.
Our costs observed were considerably higher than described 
by Shwiff et  al. (18), where a mean of 1.55 USD was grossly 
estimated for Africa, Asia, and Latin America. As the success of 
a rabies vaccination campaign depends on the coverage achieved, 
the goal is to maximize the number of animals vaccinated per 
dollar invested. Lower cost at the expense of lower coverage 
might lead to lower cost effectiveness because of ineffective con-
trol of the disease. This was illustrated in Tanzania where a study 
compared cost effectiveness for different coverage levels (16). 
As coverage depends heavily on accessibility of dogs and acces-
sibility is in turn defined by the socio-demographic, cultural, 
and economic background of the human population, costs vary 
greatly between different regions (32). Even across a limited area, 
such as the town of N’Djamena, costs vary significantly between 
different contexts (25).
Although the total number of vaccination days remained the 
same in 2013 compared to 2012 and higher costs were observed 
in the second year due to reinforcement of sensitization, the cost 
per dog vaccinated was lower in 2013. This highlights that the 
number of dogs vaccinated per day is an important factor for 
cost effectiveness of a campaign and that investment to enhance 
accessibility is beneficial.
Ongoing surveillance showed a reduction of weekly animal 
rabies incidence. Animal rabies surveillance in our study 
was based on passive reporting of suspected cases. A study in 
Tanzania suggests that a passive surveillance system is only able to 
detect 1% of actual rabies cases (33), and Townsend et al. estimate 
that only a detection success of 10% can prove the absence of 
animal rabies within the time period of 2 years (34). In our study 
reporting was boosted by a sensitization campaign, and we also 
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hypothesize that the urban context with high human density 
leads to a higher detection rate. Therefore, we are confident that 
we were able to detect at least 10% of dog rabies cases occurring 
within the city limits.
Despite the reported decline of animal rabies incidence after 
the vaccination campaigns, PEP demand did not decrease to an 
equal extent. During the analysis phase, it became evident that 
health personnel judged the rabies risk according to the severity 
of the wound inflicted and only rarely considered the animal 
background. In consequence, PEP was sometimes provided 
without real indication, causing an unnecessary burden for the 
public sector and for households with low income. Regardless 
of the investment into animal rabies, the cost effectiveness of 
PEP could be increased through better communication between 
veterinarians and human health workers and also through 
changing from the intramuscular Essen regime to an intrader-
mal protocol (17).
Overall, the predicted break-even point between dog mass 
vaccination with PEP and PEP alone in the earlier simulation (21) 
matches the observed time period under a scenario of no reintro-
duction from outside of town. The main difference to the earlier 
work is that two campaigns were needed instead of one. Given 
the suggested interruption of rabies transmission in N’Djamena 
by the high coverage achieved in both years and the subsequent 
drop in need for PEP, dog vaccination would have a higher cost 
effectiveness after 15 years, despite the high investment. This is 
due in part to the equally high cost for PEP observed in Chad. 
Even without inclusion of RIG, an entire course of PEP equals 
the cost of PEP with RIG in South Africa (35) and is considerably 
higher than in Tanzania (29). This means that if the WHO recom-
mended inclusion of RIG for Category 3 exposures was applied 
in Chad, canine vaccination would have a much higher cost 
effectiveness than described in this study. For rural areas where 
accessibility is geographically very limited, the cost for travel and 
accommodation would also be higher than that presented here 
for an urban setting.
However, on the veterinary side, costs could also be higher 
because some were not included within the calculation presented, 
for example, costs related to animal observation, surveillance, 
and diagnostics. Finally, with regard to the DALY, we only con-
sidered cost in regard to years of life lost. Rabies also leads to a 
psychological burden in families of victims and in exposed people 
who fear contracting the disease (3, 36). This psychological aspect 
of disability has not been described empirically to date but poten-
tially leads to a productivity loss and higher burden of disease.
Our results show that One Health communication is crucial to 
get a maximum return on the investment and prevent prevailing 
unnecessary high PEP cost. The overall number of DALY averted 
in scenario 2 was equal to scenario 3, but scenario 3 had higher 
cost-efficiency due to lower investment into PEP. This highlights 
that dog vaccination together with One Health communication 
allows for maximal translation of effect on rabies control in the 
animal sector to cost saving for the public health sector.
One health communication also incurs cost, for example, 
meeting fees, transport costs, and telephone credit. These costs 
were not included in the calculation due to absence of reliable 
data. Also, PEP cost calculation for scenario 3 was based on 
the assumption that, if the biting animal is not vaccinated, an 
observation period of 10 days applies, during which PEP in all 
victims is already initiated. This means that for the duration of the 
observation period 3 doses of vaccine would be needed. Currently, 
the observation period applied in Chad is 14 days, which requires 
4 doses before discontinuing the unnecessary treatment.
The cost efficiency calculation was based on the assumption 
that canine rabies transmission can be interrupted in N’Djamena 
by two vaccination rounds. Thus after 2 years, only the costs for 
prevention of reintroduction are incurred. Disease modeling and 
phylodynamic analysis of the epidemiological and molecular 
data collected during the study period suggest that interruption 
was achieved but that rabies was re-introduced from outside the 
relatively small (254 km2) vaccination area (37).
Data from ongoing routine diagnostics at IRED also show that 
without control at the town border, rapid reintroduction into the 
city occurs. The epidemiological pressure from the rural to urban 
areas is also described for Bangui and its surroundings (38). 
Therefore, sustainable control can only be achieved with either 
stringent reintroduction control for rabies free areas requiring 
movement restrictions on dogs or large scale national campaigns. 
A preliminary budget estimate for a Chadian national dog rabies 
vaccination campaign suggests costs between 1.9 and 4.7 million 
Euros, depending on the number of dogs vaccinated per day per 
vaccination post and the overall duration (22). Despite several 
limitations and assumptions, our study proves the financial 
advantage of investment into dog mass vaccination for preven-
tion of human rabies, identifies the need for better communica-
tion between the human and animal health sectors to improve 
cost effectiveness of interventions in the animal reservoir, and 
highlights the urgency for large scale control of animal rabies in 
Chad.
cOnclUsiOn
Despite the high initial cost for mass vaccination, the advantage 
of investment into rabies control in the host species is evident. 
Our results clearly show that canine mass vaccination has a 
higher cost effectiveness per DALY averted than PEP alone and 
is less costly over a period of 15–20  years. The study success-
fully demonstrates the added value of a One Health approach 
in zoonotic disease control. PEP remains the main prevention 
strategy to avert rabies deaths but compared to animal vaccina-
tion, it is not cost effective and does not lead to reduction and 
elimination of human rabies cases.
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